CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy.
Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
接受 CAR-T 细胞治疗的患者,其体验和多维照护需求在治疗的不同阶段有所不同。
描绘接受CAR-T 细胞治疗患者的治疗历程和需求,为完善临床CAR-T 患者的全程管理、改善患者整体福祉提供参考。
采用质性扎根理论方法。2024年8月至2025年1月,通过目的抽样纳入中国武汉一所大学医院接受CAR-T 治疗的患者。研究资料通过描述性观察、聚焦观察和选择性观察收集,并进行开放式、主轴式和选择性编码。采用患者历程图可视化患者体验和需求。
患者历程图包含3个主要类别、7个亚类别和1个核心类别。核心类别为治愈疾病;主要类别包括复杂的身体历程(患者与治疗副作用造成的不适抗争)、个体化的心理历程(治愈希望与副作用焦虑并存),以及治疗过程中不可预测的生理挑战和情绪波动,这些因素逐步形成多维照护需求。研究据此绘制了CAR-T 患者历程图。
CAR-T 患者在不同治疗阶段的体验和多维照护需求各异,因此医护人员应在相应阶段给予关注和支持。患者历程图可作为复盘和审核工具,也可用于推动主动、以患者为中心的照护。
To map the journey and needs of patients receiving chimeric antigen receptor T-cell (CAR-T) therapy, providing a reference for improving the comprehensive management of patients receiving clinical CAR-T cell therapy, as well as enhancing patients' overall well-being.
A qualitative grounded theory approach was used. From August 2024 to January 2025, patients receiving CAR-T cell therapy at a university hospital in Wuhan, China, were enrolled through purposive sampling. The research data were collected from descriptive observation, focused observation, and selective observation. The data were analysed with open, axial and selective coding. Patient journey mappings were employed to visualize information regarding patients' experiences and needs.
Three main categories, seven subcategories and one core category were used to map the journey of patients receiving CAR-T cell therapy. The core category was curing the disease, and the main categories were complex physical journeys characterized by the struggle against discomfort as a side effect of treatment, individualized psychological journeys created by the hope of a cure and anxiety over side effects, the unpredictable physiological challenges and emotional upheavals inherent to progressively build multidimensional care needs. Patient journey mapping of patients receiving CAR-T cell therapy was designed.
The experiences and multidimensional care needs of patients receiving CAR-T cell therapy vary at different stages of treatment. Therefore, it is essential that health care professionals provide attention and support at these times. Patient journey mapping may contribute as a review and audit tool, or a mechanism for providing proactive patient-centred care.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。